6661
威健生技
0.00 (0.00%)16.155成交張數–本益比1.38股價淨值比0.00%殖利率2026-09-11資料日期
ROE 與 ROA
近四季合計;近十年
每股淨值
元
負債比率
負債總額 / 資產總額
現金流量
單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)
| 季度 | 資產總額(億) | 母公司權益(億) | 負債比率 | 流動比率 | 每股淨值 | ROE(近四季) | ROA(近四季) | 營業現金流(億) | 自由現金流(億) |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 7 | 3 | 57.8% | 1.91 | 11.72 | -0.6% | -0.3% | 0.1 | -0.8 |
| 2026Q1 | 6 | 3 | 53.0% | 1.96 | 11.80 | -0.1% | -0.1% | -0.2 | -0.2 |
| 2025Q4 | 6 | 3 | 54.0% | 2.21 | 12.07 | 0.5% | 0.2% | 0.2 | -0.0 |
| 2025Q3 | 6 | 3 | 47.1% | 2.62 | 12.39 | 0.6% | 0.3% | 0.2 | 0.0 |
| 2025Q2 | 5 | 3 | 46.1% | 2.51 | 12.13 | 0.8% | 0.4% | -0.0 | -0.0 |
| 2025Q1 | 5 | 3 | 46.0% | 2.50 | 12.17 | 0.8% | 0.4% | -0.1 | -0.1 |
| 2024Q4 | 5 | 3 | 44.0% | 2.34 | 12.35 | 0.4% | 0.2% | 0.3 | 0.3 |
| 2024Q3 | 5 | 3 | 41.8% | 2.63 | 12.47 | -0.4% | -0.3% | 0.4 | 0.3 |
| 2024Q2 | 5 | 3 | 44.3% | 2.36 | 12.23 | -3.4% | -1.9% | -0.1 | -0.1 |
| 2024Q1 | 5 | 3 | 43.1% | 2.56 | 12.27 | -1.2% | -0.7% | -0.0 | -0.1 |
| 2023Q4 | 5 | 3 | 45.2% | 2.39 | 12.53 | -0.9% | -0.5% | 0.2 | 0.1 |
| 2023Q3 | 5 | 3 | 39.9% | 2.65 | 12.79 | -0.8% | -0.5% | -0.0 | -0.2 |
| 2023Q2 | 5 | 3 | 42.0% | 2.55 | 12.90 | 1.0% | 0.7% | -0.2 | -0.2 |
| 2023Q1 | 4 | 3 | 32.5% | 3.01 | 12.64 | 3.3% | 2.3% | 0.0 | -0.0 |
| 2022Q4 | 4 | 3 | 30.2% | 2.89 | 13.03 | 3.1% | 2.2% | 0.2 | 0.0 |
| 2022Q3 | 4 | 3 | 19.5% | 4.18 | 13.39 | 8.4% | 6.8% | 0.5 | 0.5 |
| 2022Q2 | 4 | 3 | 18.1% | 4.33 | 13.02 | 7.0% | 5.5% | 0.0 | 0.0 |
| 2022Q1 | 4 | 3 | 26.6% | 3.03 | 12.52 | 4.7% | 3.5% | -0.2 | -0.3 |
| 2021Q4 | 4 | 3 | 27.0% | 2.99 | 13.30 | – | – | 0.4 | 0.4 |
| 2021Q3 | 4 | 3 | 19.2% | 4.20 | 12.76 | – | – | 0.0 | 0.0 |
| 2021Q2 | 4 | 3 | 23.8% | 3.46 | 12.75 | – | – | -0.2 | -0.2 |
| 2021Q1 | 4 | 3 | 22.0% | 3.89 | 13.60 | – | – | -0.1 | -0.1 |